Journal of NeuroVirology

, Volume 13, Issue 6, pp 561–568 | Cite as

Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women

  • Valerie Wojna
  • Lizbeth Robles
  • Richard L. Skolasky
  • Raul Mayo
  • Ola Selnes
  • Tania de la Torre
  • Elizabeth Maldonado
  • Avindra Nath
  • Loyda M. Meléndez
  • Jose Lasalde-Dominicci
Article

Abstract

Cigarette smoking alters the immune system and may improve cognitive deficits in neuropsychiatric disorders. Smoking prevalence is high in human immunodeficiency virus (HIV)—infected patients; however, its effect on HIV-associated cognitive impairment remains unknown in the era of antiretroviral treatment. The authors examined associations of smoking with viral immune profile and cognitive function in a cohort of HIV-seropositive women. This observational cross-sectional study included 56 women (36 HIV-seropositive and 20 HIV-seronegative) surveyed with a tobacco questionnaire: the Fagerström Test for Nicotine Dependency. Viral immune status was obtained 6 to 12 months before questioned. Neurocognitive testing (NP) assessed verbal memory, frontal/executive function, psychomotor speed, and motor speed. A reference group of HIV-seronegative women was used to calculate standardized z-scores. Cognitive impairment was classified using a modified American Academy of Neurology criteria, adding an asymptomatic group based on NP tests. Statistics included parametric and nonparametric tests. HIV-seropositive women were more likely to report a history of smoking (P = 0.028). Among them, current smoking correlated with higher plasma viral load (P = 0.048), and history of smoking correlated with lower CD4 cell count (P = 0.027). The authors observed no associations between cognitive impairment and either current or past history of smoking and no differences in neurocognitive domain scores between HIV-seropositive and -seronegative women or between those with and without a history of smoking. However, restricting analysis to HIV-seropositives showed a significant better performance on the frontal/executive domain in those with history of smoking. In summary, history of smoking correlated with better frontal/executive cognitive domain performance in HIV-seropositive women and with worse viral immune profile.

Keywords

cigarette smoking cognitive impairment HIV nicotine viral immune profile women 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Academy of Neurology AIDS Task Force (1991). Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41: 778–785.Google Scholar
  2. American Academy of Neurology AIDS Task Force (1996). Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Neurology 47: 1247–1253.Google Scholar
  3. Becona E, Vazquez FL (1998). The Fagerstrom Test for Nicotine Dependence in a Spanish sample. Psychol Rep, 83: 1455–1458.CrossRefPubMedGoogle Scholar
  4. Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P 3rd (2006). Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther 79: 480–488.CrossRefPubMedGoogle Scholar
  5. Burns DN, Kramer A, Yellin F, Fuchs D, Wachter H, DiGioia RA, Sanchez WC, Grossman RJ, Gordin FM, Biggar RJ, Goedert JJ (1991). Cigarette smoking: a modifier of human immunodeficiency virus type 1 infection? J Acquir Immune Defic Syndr 4: 76–83.PubMedGoogle Scholar
  6. CDC (2006). HIV/AIDS among Youth. http://www.cdc. gov/hiv/resourses/factsheets/youth.htm.Google Scholar
  7. Conley LJ, Bush TJ, Buchbinder SP, Penley KA, Judson FN, Holmberg SD (1996). The association between cigarette smoking and selected HIV-related medical conditions. AIDS 10: 1121–1126.PubMedGoogle Scholar
  8. Crothers K, Griffith TA, McGinnis KA, Rodriguez-Barradas MC, Leaf DA, Weissman S, Gibert CL, Butt AA, Justice AC (2005). The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 20: 1142–1145.CrossRefPubMedGoogle Scholar
  9. Dani JA, Bertrand D (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47: 699–729.CrossRefPubMedGoogle Scholar
  10. Davis TM, Rodriguez VL (1979). Comparison of scores on the WAIS and its Puerto Rican counterpart, Escala de Inteligencia Wechsler para Adultos, in an institutionalized Latin American psychiatric population. J Consult Clin Psychol 47: 181–182.CrossRefPubMedGoogle Scholar
  11. de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM (1995). Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry 152: 453–455.PubMedGoogle Scholar
  12. De Simone R, Ajmone-Cat MA, Carnevale D, Minghetti L (2005). Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J Neuroinflamm 2: 4.CrossRefGoogle Scholar
  13. Demsky YI, Gass CS, Golden CJ (1998). Interpretation of VIQ-PIQ and intersubtest differences on the Spanish version of the WAIS. Assessment 5: 25–30.CrossRefPubMedGoogle Scholar
  14. Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, Gandhi M, Mocharnuk RS, Anastos K (2006). Association of cigarette smoking with hiv prognosis among women in the HAART era: a report from the Women’s Interagency HIV Study. Am J Public Health 96: 1060–1065.CrossRefPubMedGoogle Scholar
  15. Furber AS, Maheswaran R, Newell JN, Carroll C (2007). Is smoking tobacco an independent risk factor for HIV infection and progression to AIDS? A systemic review. Sex Transm Infect 83: 41–46.CrossRefGoogle Scholar
  16. Galanis DJ, Petrovitch H, Launer LJ, Harris TB, Foley DJ, White LR (1997). Smoking history in middle age and subsequent cognitive performance in elderly Japanese-American men. The Honolulu-Asia Aging Study. Am J Epidemiol 145: 507–515.PubMedGoogle Scholar
  17. Giunta B, Ehrhart J, Townsend K, Sun N, Vendrame M, Shytle D, Tan J, Fernandez F (2004). Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120. Brain Res Bull 64: 165–170.CrossRefPubMedGoogle Scholar
  18. Gonzalez-Lira B, Rueda-Orozco PE, Galicia O, Montes-Rodriguez CJ, Guzman K, Guevara-Martinez M, Elder JH, Prospero-Garcia O (2006). Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats. Neurosci Lett 394: 136–139.CrossRefPubMedGoogle Scholar
  19. Gritz ER, Vidrine DJ, Lazev AB, Amick BC 3rd, Arduino RC (2004). Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res 6: 71–77.CrossRefPubMedGoogle Scholar
  20. Hilditch JR, Lewis J, Peter A, van Maris B, Ross A, Franssen E, Guyatt GH, Norton PG, Dunn E (1996). A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 24: 161–175.PubMedGoogle Scholar
  21. Hill RD, Nilsson LG, Nyberg L, Backman L (2003). Cigarette smoking and cognitive performance in healthy Swedish adults. Age Ageing 32: 548–550.CrossRefPubMedGoogle Scholar
  22. Holt PG (1987). Immune and inflammatory function in cigarette smokers. Thorax 42: 241–249.CrossRefPubMedGoogle Scholar
  23. Hosli E, Ruhl W, Hosli L (2000). Histochemical and electrophysiological evidence for estrogen receptors on cultured astrocytes: colocalization with cholinergic receptors. Int J Dev Neurosci 18: 101–111.CrossRefPubMedGoogle Scholar
  24. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA (1986). Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 143: 993–997.PubMedGoogle Scholar
  25. Mamary EM, Bahrs D, Martinez S (2002). Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS 16: 39–42.CrossRefPubMedGoogle Scholar
  26. Masterson E, O’Shea B (1984). Smoking and malignancy in schizophrenia. Br J Psychiatry 145: 429–432.CrossRefPubMedGoogle Scholar
  27. MMWR (2006). Use of cessation methods among smokers aged 16–24 years—United States, 2003. MMWR Mort Morb Wkly Rep 55: 1351–1354.Google Scholar
  28. Mueck AO, Seeger H (2005). Smoking, estradiol metabolism and hormone replacement therapy. Curr Med Chem Cardiovasc Hematol Agents 3: 45–54.CrossRefPubMedGoogle Scholar
  29. Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB (2000). Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis 31: 808–812.CrossRefPubMedGoogle Scholar
  30. O’Farrell TJ, Connors GJ, Upper D (1983). Addictive behaviors among hospitalized psychiatric patients. Addict Behav 8: 329–333.CrossRefPubMedGoogle Scholar
  31. Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, Ellis J, Zerbe GO, Leonard S, Stevens KE, Stevens JO, Martin L, Adler LE, Soti F, Kem WR, Freedman R (2006). Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 63: 630–638.CrossRefPubMedGoogle Scholar
  32. Ott A, Andersen K, Dewey ME, Letenneur L, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A, Launer LJ (2004). Effect of smoking on global cognitive function in nondemented elderly. Neurology 62: 920–924.PubMedGoogle Scholar
  33. Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W, Jr. (1996). Comorbidity and survival in HIV-infected men in the San Francisco Men’s Health Survey. Ann Epidemiol 6: 420–430.CrossRefPubMedGoogle Scholar
  34. Perkins KA (2001). Smoking cessation in women. Special considerations. CNS Drugs 15: 391–411.CrossRefPubMedGoogle Scholar
  35. Perkins KA, Doyle T, Ciccocioppo M, Conklin C, Sayette M, Caggiula A (2006). Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking. Psychopharmacology (Berl) 184: 600–607.CrossRefGoogle Scholar
  36. Poundstone KE, Chaisson RE, Moore RD (2001). Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS 15: 1115–1123.CrossRefPubMedGoogle Scholar
  37. Razani J, Boone K, Lesser I, Weiss D (2004). Effects of cigarette smoking history on cognitive functioning in healthy older adults. Am J Geriatr Psychiatry 12: 404–411.PubMedGoogle Scholar
  38. Richards M, Jarvis MJ, Thompson N, Wadsworth ME (2003). Cigarette smoking and cognitive decline in midlife: evidence from a prospective birth cohort study. Am J Public Health 93: 994–998.CrossRefPubMedGoogle Scholar
  39. Royce RA, Winkelstein W Jr (1990). HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: preliminary results from the San Francisco Men’s Health Study. AIDS 4: 327–333.CrossRefPubMedGoogle Scholar
  40. Sacco KA, Bannon KL, George TP (2004). Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol 18: 457–474.CrossRefPubMedGoogle Scholar
  41. Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, Jatlow PI, Wexler BE, George TP (2005). Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 62: 649–659.CrossRefPubMedGoogle Scholar
  42. Shytle RD, Mori T, Townsend K, Vendrame M, Sun N, Zeng J, Ehrhart J, Silver AA, Sanberg PR, Tan J (2004). Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem 89: 337–343.CrossRefPubMedGoogle Scholar
  43. Sopori M (2002). Effects of cigarette smoke on the immune system. Nat Rev Immunol 2: 372–377.CrossRefPubMedGoogle Scholar
  44. Svensson AL, Nordberg A (1999). Beta-estradiol attenuate amyloid beta-peptide toxicity via nicotinic receptors. Neuroreport 10: 3485–3489.CrossRefPubMedGoogle Scholar
  45. Tollerud DJ, Brown LM, Blattner WA, Mann DL, Pankiw-Trost L, Hoover RN (1991). T cell subsets in healthy black smokers and nonsmokers. Evidence for ethnic group as an important response modifier. Am Rev Respir Dis 144: 612–616.PubMedGoogle Scholar
  46. Tollerud DJ, Clark JW, Brown LM, Neuland CY, Mann DL, Pankiw-Trost LK, Blattner WA, Hoover RN (1989). The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians. Am Rev Respir Dis 139: 1446–1451.PubMedGoogle Scholar
  47. Tracey KJ (2002). The inflammatory reflex. Nature 420: 853–859.CrossRefPubMedGoogle Scholar
  48. Turner J, Page-Shafer K, Chin DP, Osmond D, Mossar M, Markstein L, Huitsing J, Barnes S, Clemente V, Chesney M (2001). Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care STDS 15: 615–624.CrossRefPubMedGoogle Scholar
  49. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ (2003). Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421: 384–388.CrossRefPubMedGoogle Scholar
  50. Williams, J (2002). Women and smoking: sensory factors, attitudes about weight, phase of menstrual cycle all key to quitting. NIDA notes.Google Scholar
  51. Wojna V, Nath A (2006). Challenges to the diagnosis and management of HIV dementia. AIDS Read 16: 615–616, 621–624, 626, 629–632.PubMedGoogle Scholar
  52. Wojna V, Skolasky R, Hechavarria R, Mayo R, Selnes O, McArthur JC, Melendez L, Maldonado E, Zorrilla C, Garcia H, Kraiselburd E, Nath A (2006). Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J NeuroVirol 12: 1–9.CrossRefGoogle Scholar
  53. Ziedonis DM, Kosten TR, Glazer WM, Frances RJ (1994). Nicotine dependence and schizophrenia. Hosp Community Psychiatry 45: 204–206.PubMedGoogle Scholar

Copyright information

© Journal of NeuroVirology, Inc. 2007

Authors and Affiliations

  • Valerie Wojna
    • 1
    • 2
  • Lizbeth Robles
    • 1
  • Richard L. Skolasky
    • 3
  • Raul Mayo
    • 1
    • 4
  • Ola Selnes
    • 5
  • Tania de la Torre
    • 1
  • Elizabeth Maldonado
    • 1
  • Avindra Nath
    • 5
  • Loyda M. Meléndez
    • 1
    • 6
  • Jose Lasalde-Dominicci
    • 1
    • 7
  1. 1.NeuroAIDS ProgramUniversity of Puerto RicoSan JuanPuerto Rico
  2. 2.Department of Internal Medicine, Neurology SectionUniversity of Puerto RicoSan JuanPuerto Rico
  3. 3.Department of Orthopedic SurgeryJohns Hopkins UniversityBaltimoreUSA
  4. 4.Department of Physical Medicine and RehabilitationUniversity of Puerto RicoSan JuanPuerto Rico
  5. 5.Department of NeurologyJohns Hopkins UniversityBaltimoreUSA
  6. 6.Department of MicrobiologyUniversity of Puerto RicoSan JuanPuerto Rico
  7. 7.Department of Biology and ChemistryUniversity of Puerto RicoSan JuanPuerto Rico

Personalised recommendations